US 9,808,504 B2
Immunogenic epitopes as targets for universal cancer vaccines
Kavita Dhodapkar, New Haven, CT (US); and Madhav Dhodapkar, New Haven, CT (US)
Assigned to Yale University, New Haven, CT (US)
Appl. No. 13/387,676
Filed by Kavita Dhodapkar, New Haven, CT (US); and Madhav Dhodapkar, New Haven, CT (US)
PCT Filed Sep. 22, 2010, PCT No. PCT/US2010/049823
§ 371(c)(1), (2), (4) Date Apr. 19, 2012,
PCT Pub. No. WO2011/038002, PCT Pub. Date Mar. 31, 2011.
Claims priority of provisional application 61/277,285, filed on Sep. 22, 2009.
Prior Publication US 2012/0207775 A1, Aug. 16, 2012
Int. Cl. A61K 39/00 (2006.01); A61K 38/17 (2006.01); A61K 39/39 (2006.01)
CPC A61K 38/1709 (2013.01) [A61K 39/0011 (2013.01); A61K 39/39 (2013.01)] 4 Claims
 
1. A composition comprising a plurality of OCT4 peptides, each said OCT4 peptide consisting of a peptide selected from the group consisting of SEQ ID NO: 53 and SEQ ID NO: 74, and further comprising an adjuvant, and one or more pharmaceutically acceptable excipients.